ClinicalTrials.gov research-record snapshot for Philadelphia, PA
Snapshot scope: This page is a static ClinicalTrials.gov research-record snapshot retrieved on . The fixed source query returned 19 results; after an exact city/state check of listed facilities, 18 records were retained for Philadelphia, Pennsylvania. It is not a clinic, enrollment, or local-availability directory.
Snapshot methodology and exact-location matching
City/state source filter
Philadelphia, Pennsylvania
Exact-location inclusion rule
A listed facility city and state must match Philadelphia, Pennsylvania.
Records are retained only after the listed facility location matches the fixed city and state. This location match does not establish enrollment, site activity, eligibility, or local availability.
Fixed query terms
semaglutide
tirzepatide
cagrilintide
retatrutide
tesamorelin
sermorelin
ipamorelin
bpc-157
thymosin alpha 1
pt-141
Included study statuses
RECRUITING
NOT_YET_RECRUITING
ACTIVE_NOT_RECRUITING
ENROLLING_BY_INVITATION
How to read this snapshot
Research-record limits
This is not a clinic, enrollment, local-service, or local-availability directory.
Why Peptides does not recommend sites, assess eligibility, or provide medical advice.
A listing or study-level status does not prove enrollment, eligibility, safety, effectiveness, or availability.
Each displayed registry status is a study-level overall status, not a facility enrollment status.
Links on this page lead only to the cited ClinicalTrials.gov source records and search pages.
Records are a fixed snapshot, not a complete or live catalog.
All retained records
Study-level status mix
The counts below summarize every retained record in this snapshot. They describe registry study status only, not whether a particular facility is enrolling.
RECRUITING
6 records
NOT_YET_RECRUITING
3 records
ACTIVE_NOT_RECRUITING
9 records
ENROLLING_BY_INVITATION
0 records
Records in this snapshot
Retained ClinicalTrials.gov NCT records
The retrieved source snapshot contains 18 exact-location records and 15 listed facilities. All 18 retained records are shown below.
Registry title: A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight
Registry title: Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
Study-level overall status
RECRUITING
Record update date
Exact-matched listed facility/location
Thomas Jefferson University - Medicine/GI and HepatologyPhiladelphia, Pennsylvania 19107
Registry title: Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
Study-level overall status
RECRUITING
Record update date
Exact-matched listed facility/location
Thomas Jefferson University - Medicine/GI and HepatologyPhiladelphia, Pennsylvania 19107
Registry title: A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Placebo in Children and Adolescents With Type 2 Diabetes
Registry title: Cessation or Reduction of Alcohol Consumption in Veterans: A Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial to Evaluate the Efficacy and Safety of a GLP-1 Receptor Agonist Semaglutide in U.S. Veterans With Alcohol Use Disorder
Study-level overall status
NOT_YET_RECRUITING
Record update date
Exact-matched listed facility/location
Corporal Michael J. Crescenz VA Medical Center, Philadelphia, PAPhiladelphia, Pennsylvania 19104-4551
Registry title: Effect of Retatrutide Compared With Semaglutide in Adult Participants With Type 2 Diabetes and Inadequate Glycemic Control With Metformin With or Without SGLT2 Inhibitor (TRANSCEND-T2D-2)
Study-level overall status
ACTIVE_NOT_RECRUITING
Record update date
Exact-matched listed facility/location
Thomas Jefferson University HospitalPhiladelphia, Pennsylvania 19107
Registry title: A Study of Tirzepatide Compared With Intensified Conventional Care in Adult Participants With Type 2 Diabetes
Study-level overall status
ACTIVE_NOT_RECRUITING
Record update date
Exact-matched listed facility/location
Clinical Research of PhiladelphiaPhiladelphia, Pennsylvania 19114
Source retrieval and snapshot limits
Source-query results versus exact-location records
At retrieval, the fixed ClinicalTrials.gov source query returned 19 results. After an exact city/state check of listed facilities, 18 records were retained for Philadelphia, Pennsylvania, across 15 listed facilities. All 18 retained records are shown on this page.
Source retrieved
Record update dates
Shown for each displayed NCT record, as supplied by ClinicalTrials.gov
Live search scope: This broader live search does not reproduce the included-status filter used for this snapshot, so it can show other study statuses and change after source retrieval.
Snapshot limits: The retrieval timestamp records when Why Peptides retrieved the ClinicalTrials.gov source query; it is not an independent validation. Record update dates are supplied by ClinicalTrials.gov and can differ from the retrieval timestamp. This static snapshot is not a complete or live catalog and can become stale. Why Peptides has not independently validated record details, facilities, enrollment, contacts, eligibility, or site status. For a displayed study, open its linked ClinicalTrials.gov NCT record for current contacts, eligibility, and site status.